Journal article

Cost-Effectiveness of Nasal High Flow Versus CPAP for Newborn Infants in Special-Care Nurseries

Li Huang, Brett J Manley, Gaston RB Arnolda, Louise S Owen, Ian MR Wright, Jann P Foster, Peter G Davis, Adam G Buckmaster, Kim M Dalziel



BACKGROUND: Treating respiratory distress in newborns is expensive. We compared the cost-effectiveness of 2 common noninvasive therapies, nasal continuous positive airway pressure (CPAP) and nasal high-flow (nHF), for newborn infants cared for in nontertiary special care nurseries. METHODS: The economic evaluation was planned alongside a randomized control trial conducted in 9 Australian special care nurseries. Costs were considered from a hospital perspective until infants were 12 months of age. A total of 754 infants with respiratory distress, born ≥31 weeks' gestation and with birth weight ≥1200 g, 1 hour were recruited during 2015-2017. Inpatient costing records were obtained for 753 inf..

View full abstract


Awarded by National Health and Medical Research Council

Funding Acknowledgements

Funded by the National Health and Medical Research Council (1098790). The sponsor had no involvement in the study design, the collection, analysis, and interpretation of data, the writing of the report, and the decision to submit the manuscript for publication.